Content by Synthego

Overcome drug resistance by targeting host proteins.

Using sgRNA libraries for target identification and validation during drug discovery

Experience the past, present, and future of CRISPR technology.

Learn how researchers use CRISPR-mediated loss-of-function screens in drug discovery.

First-of-its-kind Platform Enables Scalable CRISPR-based Cell Engineering

Presented at ELRIG’s CRISPR in Drug Discovery 2020, the Award Underscores the Impact of Synthego’s Screening Libraries to Support Full Continuum of Therapy Discovery and Development

National Institutes of Health awards contract for CRISPR-based disease modeling in iPS cell lines associated with Alzheimer’s, Stem cell pioneer Bill Skarnes joins advisory board

Novel bioinformatics-powered multi-guide design guarantees gene knockouts in any human-derived cell type, eliminating trial-and-error in CRISPR guide design

New online tools make sophisticated CRISPR guide design fast and easy for all researchers

CRISPRevolution EZ sgRNA Kit